By ISOCHEM S.A.S
To get in touch with Isochem brings revitalized custom synthesis to DCAT Week, simply fill out the form below.
Subscribe to Supplier
Isochem brings revitalized custom synthesis to DCAT Week
Vert-Le-Petit, France:– Fine chemicals and active ingredients specialist CMO Isochem will field a strong suite of offers and opportunities when it attends next month’s prestige DCAT Week industry show in New York City.
“DCAT week provides us with a superb platform to meet out many North American pharmaceutical customers and prospects,” said Isochem’s Vice President Sales & Business Development, Amélie Arbore, who will be leading the company’s DCAT team in New York, in association with North American partner, Chaysechem.
Fine chemical services
“We’ll be looking to talk to any company that needs fine chemical services, from development to production, in cGMP regimes,” said Arbore.
“That could include development managers, supply or outsourcing managers for clinical phase APIs for any big pharma or biotech companies developing new drugs, especially new chemical entities,” she added.
Isochem’s presence at DCAT will be heralded by a special feature in Chemistry Today magazine, in which several members of the company’s management team are interviewed.
“Our message at DCAT will be compelling: that our full service custom manufacturing offers cGMP development and manufacturing, with continuous attention to customer needs, flexibility, risk management, communication, supply chain reliability and sustainability, including raw materials sourcing activities and business continuity plans,” said Arbore.
In particular, Isochem presenting newly developed offers on for development projects, made possible by ramping up its teams and capabilities in R&D and project management.
The year since the 2015 DCAT event has seen Isochem enjoy strong growth and productivity gained from its strategy of refocusing on pharmaceutical business opportunities. Main growth drivers have been increased demand for its custom synthesis products, along with the company’s catalog products, generic APIs and excipients. Isochem has also significantly raised its profile in North America.
“Our capabilities now include full cGMP manufacturing, route selection, process and analytical development and process optimization from laboratory scale to full production, as well as delivery of safe implementation of hazardous reactions and versatile chemistry,” said Arbore.
Isochem S.A.S. is a contract manufacturer with a century-old heritage in fine chemistry and a 40-year track record in providing high quality fine chemicals, API building blocks and high value molecules, as well as mastering complex processes. The company can manufacture products and provide services to the most recent and stringent pharmaceutical regulatory standards.
Isochem serves a broad range of customers in many application fields, from leading global companies to virtual and emerging organizations, offering services in three pharma-related fields: custom synthesis, high technology manufacturing in multi-step chemical synthesis including the safe implementation of hazardous reactions, and direct supply of more than 2,300 specific compounds and products, including phosgene derivatives, regulated and non-regulated intermediates and active ingredients.
Isochem can also provide attractive synthetic tools such as activated aminoacids building blocks (N-CarboxyAnhydride NCA) used in peptide chemistry. It is also expert in process optimization from pre-clinical development to full-scale production.
Isochem is now an international company with some 350 employees worldwide. The Head office is located near Paris, in Vert-Le-Petit, France, on one of Isochem’s five manufacturing sites. The company is a wholly owned subsidiary of Munich-based Aurelius AG.
About DCAT Week
The Drug, Chemical & Associated Technologies Association (DCAT), founded in 1890, has become North America’s premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical and chemical industries.
DCAT represents the entire spectrum of the pharmaceutical industry—from pharmaceutical, API, and excipient sales and manufacturing to distribution, support technologies and packaging products and services.
Attended by thousands of industry professionals, DCAT Week® and the DCAT Annual Dinner, held each March in New York City, are considered one of the pharma industry’s premier events.
DCAT Week 2016 will take place over four days from March 14 to March 17 and will once again be centered on New York’s landmark Waldorf Astoria Hotel.
Unlike most industry exhibitions, DCAT Week is not a trade show with stands or booths. Instead, DCAT members hold high-level strategic meetings with customers and suppliers in a block of business meeting suites across a range of prestige NYC hotels, including the New York Palace, Lexington and Hyatt 48 Lex.
DCAT members make their own appointments, some scheduling upwards of 100 meetings during the week.
More information at: https://www.dcat.org/